India, April 29 -- OneSource Specialty Pharma announced that its partner Dr. Reddy's Laboratories has received a Notice of Compliance from Health Canada for Semaglutide Injection, a generic version of Ozempic'. OneSource serves as the CDMO partner on this program, providing scale-up and manufacturing support.The partnership is designed to ensure reliable and scalable commercial supply from OneSource's US-FDA approved flagship manufacturing facility in Bengaluru.
Published by HT Digital Content Services with permission from Pivotal Sources....